Literature DB >> 11007011

The commercial production of specific-pathogen-free eggs and chickens: the evolution of an industry.

R E Luginbuhl1.   

Abstract

Entities:  

Mesh:

Year:  2000        PMID: 11007011

Source DB:  PubMed          Journal:  Avian Dis        ISSN: 0005-2086            Impact factor:   1.577


× No keyword cloud information.
  6 in total

1.  An observational study of the temporal and spatial patterns of Marek's-disease-associated leukosis condemnation of young chickens in the United States of America.

Authors:  David A Kennedy; John R Dunn; Patricia A Dunn; Andrew F Read
Journal:  Prev Vet Med       Date:  2015-05-08       Impact factor: 2.670

Review 2.  Specific Pathogen Free - A review of strategies in agriculture, aquaculture, and laboratory mammals and how they inform new recommendations for laboratory zebrafish.

Authors:  Katrina N Murray; Tannia S Clark; Myron J Kebus; Michael L Kent
Journal:  Res Vet Sci       Date:  2021-11-20       Impact factor: 2.554

3.  Comparative analysis of the intestinal bacterial and RNA viral communities from sentinel birds placed on selected broiler chicken farms.

Authors:  J Michael Day; Brian B Oakley; Bruce S Seal; Laszlo Zsak
Journal:  PLoS One       Date:  2015-01-30       Impact factor: 3.240

4.  Evaluation of the pathogenicity of West Nile virus (WNV) lineage 2 strains in a SPF chicken model of infection: NS3-249Pro mutation is neither sufficient nor necessary for conferring virulence.

Authors:  Maha Dridi; Thierry Van Den Berg; Sylvie Lecollinet; Benedicte Lambrecht
Journal:  Vet Res       Date:  2015-10-30       Impact factor: 3.683

5.  Designing A Transgenic Chicken: Applying New Approaches toward A Promising Bioreactor.

Authors:  Salahadin Bahrami; Amir Amiri-Yekta; Abbas Daneshipour; Seyedeh Hoda Jazayeri; Paul Edward Mozdziak; Mohammad Hossein Sanati; Hamid Gourabi
Journal:  Cell J       Date:  2019-10-14       Impact factor: 2.479

6.  Opinion: The use of chicken IgY in the control of pandemics.

Authors:  Michael G Wallach
Journal:  Front Immunol       Date:  2022-08-11       Impact factor: 8.786

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.